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Abstract
Introduction 
Pregnancies with a macrosomic fetus are high-risk pregnancies and the incidence appears to 
be rising. The aim of our research was to identify the clinical profile of mothers who gave 
birth to macrosomic infants, and to study the maternal and neonatal complications associated 
with delivering infants with a birth weight of 4000 grams or greater. 
Methods 
Retrospective study involving a total of 238 deliveries of macrosomic babies from 1
st
 July
2012 to 1
st
 July 2013 at King Edward VIII Hospital, Durban. The study concerned the clinical
profile of mothers who give birth to a macrosomic infant including the risk factors, mode of 
delivery and the incidence of maternal and perinatal complications. Data was analyzed using 
SPSS (version 23). 
Results 
Macrosomia occurred in 3.4% of all deliveries. Main risk factors for macrosomia were 
previous history of macrosomia, male sex, hypertensive disorders of pregnancy, body mass 
index ≥25, para 1 and 2, diabetes and higher gestational age at delivery. Majority of 
macrocosmic infants were born to non-diabetic women in our audit. 
Moreover, macrosomia increased delivery complications for both mothers and newborns. 
Neonatal complications included: shoulder dystocia was noted in 2.4%, respiratory distress 
(3.4%) neonatal jaundice (5.1%), and admission to nursery was noted in 99.6% of the cases 
and for a median duration of 1 day (range 1–11 days). Hypoglycemia complicated 18.6% of 
deliveries. Twenty (8.4%) infants were resuscitated. The stillbirth rate was 0.4%. Maternal 
complications included prolonged labour (5.9%), caesarean delivery (64.3%), post- partum 
haemorrhage documented in 25.2% of cases and perineal tears and cervical lacerations was 
noted in 34.1% of vaginal deliveries. There was a significant difference in the percentage of 
neonatal morbidity in the infants delivered vaginally compared to caesarean delivery (48.2% 
vs 7.8%; p<0.02). No maternal deaths occurred. 
Conclusion 
The prevalence of macrosomia was 3.4%. Main risk factors for macrosomia were previous 
history of macrosomia, male sex, hypertensive disorders of pregnancy, body mass index ≥25, 
para 1 and 2, diabetes and higher gestational age at delivery. Mother and neonate are at 
increased risk of complications. 
ix 
Introduction 
1.0 Background 
Macrosomia is a term used to describe a large fetus or neonate weighing ≥ 4000g at term 
1.The Pedersen’s hypothesis, which was suggested more than sixty years ago, links fetal 
macrosomia to the transplacental passage of excessive maternal glucose, which leads to fetal 
hyperglycaemia and excessive fetal insulin release
2
.Since its introduction, the Pedersen
hypothesis has been further extended by other investigators and accepted as the 
pathophysiologic basis for increased risk of macrosomia among infants of women with 
diabetes during pregnancy 
3 – 5
 .
There is no universally accepted definition of fetal macrosomia. While some clinicians 
believe that infants with birth weight ≥ 4000 g or above the 90th percentile for the population
and sex-specific growth curve can be said to be macrocosmic, others have used birth weight ≥ 
4500 g 
6,7
.The American College of Obstetricians and Gynecologists (ACOG) defined 
macrosomia as birth-weight over 4,000 g irrespective of gestational age or greater than the 
90
th
 percentile for gestational age after correcting for neonatal sex and ethnicity 
8
.  There has
been further interest in the group of infants whose birth weight exceeds 5000 g 9.
1.1 Prevalence of macrosomia 
The prevalence of fetal macrosomia varies between 0 -15%
10 
but the higher prevalence have
been reported in higher income countries compared to low and middle income 
countries
11,12
.The prevalence of macrosomia varies in sub-Saharan countries between 1.9 %
in Ethiopia and 14.6 % in Nigeria 
13
. In Cameroon, its prevalence in 1995 was 6.4 % 
14
. In
South Africa, the prevalence was 3.4% in 1995 
15
. A study from Denmark indicated an
increase in the frequency of macrosomia from 16.7% in 1990 to 20.0% in 1999 
16
.
1 
A number of risk factors associated with macrosomia have been identified, and include 
maternal body mass index, weight gain, advanced maternal age, multiparity, diabetes, and 
gestational age >41 weeks
17, 18
.  However, it is well known that prediction based on clinical
risk factors alone and together with first trimester nuchal translucency and biochemical 
markers (free beta-human chorionic gonadotropin and pregnancy associated plasma protein A 
has a very low positive predictive value
19, 20
.Non-modifiable factors include genetics, fetal
sex, parity, maternal age and height. Modifiable factors include pre-gestational maternal 
anthropometric characteristics (BMI), gestational weight gain and maternal glucose 
metabolism.  
Race and ethnicity are associated with macrosomia
1, 21
.The incidence of macrosomia varies
according to ethnicity, and is lower in the Chinese population. This difference in birth weight 
distribution is likely due to the genetic differences and anthropometric discrepancies between 
populations. From a recent study, the incidence of macrosomia in Chinese population was 
reported to be only 3.4%
21
.
Factors associated with fetal macrosomia include genetics, duration of gestation, presence of 
gestational diabetes, and diabetes mellitus types I and II. Genetic, racial, and ethnic factors 
influence birth weight and the risk of macrosomia
22
.  Maternal diabetes is one of the strongest
risk factors associated with giving birth to an infant that is considered large for gestational 
age. Pre-gestational and gestational diabetes result in fetal macrosomia in as many as 50% of 
pregnancies complicated by gestational diabetes and in 40% of those complicated by type 1 
diabetes mellitus. Esseland Opai-Tetteh(1995) showed that the risk of macrosomia increases 
with maternal age
15
.
Primary concern about the birth of a macrosomic fetus is adverse neonatal outcomes 
including stillbirth and neonatal mortality secondary to birth asphyxia, shoulder dystocia, 
birth injury, metabolic disorders, and meconium aspiration syndrome. The occurrence of 
these unfavourable outcomes and their risks factors have been widely studied 
23 - 25
.
2 
Similarly, maternal complications such as increased risk of caesarean delivery, postpartum 
haemorrhage and perineal lacerations are increased in the setting of fetal macrosomia 
17, 26 – 
28
. Maternal and neonatal complications are shown in boxes 1 and 2. 
Box 1 Box 2 
1.2 Maternal complications 
1.2 Maternal complications 
1.2.1 Prolonged labour 
The duration of labour is more prolonged for women carrying macrosomic babies, and the 
risk is increased with increasing birth weight
29
. Both the first and second stages of labour are
longer than for normosomic pregnancies, and arrest of descent in the second stage of labour 
can occur secondary to macrosomia
30
. In a study of macrosomic infants weighing more than
4,500 g, the risk of shoulder dystocia is higher when the second stage is longer than 2 hours, 
with a crude odds ratio (OR) of 1.17 (95% confidence interval [CI] 0.82–1.66)24. Prolonged
labour associated with macrosomia is, in turn, a contributor to other maternal complications, 
including operative delivery and postpartum haemorrhage. 
3 
Maternal complications 
 Prolonged labour
 Operative delivery
 Postpartum haemorrhage
 Perineal trauma
Neonatal complications 
 Shoulder dystocia
 Birth trauma
 Brachial plexus injury
 Skeletal injuries
 Chorioamnionitis
 Aspiration of meconium
 Perinatal asphyxia
 Poor Apgar scores
 Neonatal hypoglycemia
 Intrauterine fetal death
1.2. 2 Operative deliveries 
The incidences of vaginal operative delivery and caesarean section are higher for macrosomic 
infants
24, 29, 31, 32
.The overall rate of caesarean section in babies with a birth weight >4,000 g 
varies widely between different studies and ranges from 14% to 44%
33, 34
. The risk of 
caesarean section escalates with increasing birth weight, and the proportion of vaginal 
instrumental delivery decreases with increasing birth weight
29, 31
. The increased risk of 
caesarean section is a consistent finding in different countries and in different ethnic groups, 
and the odds are particularly high for primiparous mothers
35
. In macrosomic births, the risk of 
shoulder dystocia is associated with the need for vaginal instrumental delivery
24
. 
1.2.3 Postpartum haemorrhage 
Postpartum haemorrhage occurs more commonly following delivery of macrosomic babies
29, 
36
 and again, the risk increases with increasing birth weight
31
.  
1.2.4 Perineal trauma 
The risk of perineal tears increases 1.5-fold to 2-fold in cases of macrosomia
37, 38
. Some 
investigators suggest that the incidence of major perineal tear rises significantly with greater 
birth weight
39 
but this has been refuted
31
. The risk appears to be higher in Asian, Filipino, and 
Indian women than in Caucasian women
37
. Such differences in the anatomy of the 
perineum, such as perineal body length and thickness among different ethnic groups, may be 
contributing factors
40
. Major perineal trauma, including third and fourth degree tear, can 
cause significant long-term anal incontinence, which can have a negative impact on the 
woman’s quality of life. 
1.3 Fetal and neonatal complications 
Although the literature frequently and consistently demonstrates an increase in perinatal 
morbidity and mortality with increasing birth weight, the overall incidence of neonatal 
complications remains low
40
. 
 
 
 
4 
1.3.1 Shoulder dystocia 
The incidence of shoulder dystocia ranges between 0.58% and 0.70% in Caucasians
41
. It also 
appears to vary with ethnicity, with an incidence of only 0.3% in the Chinese population
42
. It 
has been reported consistently in the literature that the risk of shoulder dystocia escalates with 
increasing birth weight
42 – 44
. However, the incidence of shoulder dystocia in different birth 
weight groups varies widely between studies. In a recent study in Norway, the incidence was 
approximately 1%, 2%, 4%, and 6% for birth weights of 4,000–4,199 g, 4,200–4,399 g, 
4,400–4,599 g, and ≥4,600 g44, respectively, whereas another study reported an incidence of 
over 20% when the birth weight was above 4,500 g. Nevertheless, despite such an 
association, half or even more of the births complicated by shoulder dystocia occur in babies 
with a birth weight less than 4,000 g
42
. 
1.3.2 Birth trauma 
The incidence of birth trauma, namely brachial plexus and skeletal injuries, increases with 
rising birth weight
25, 29
. 
1.3.3 Brachial plexus injury 
Congenital brachial plexus injury is defined as flaccid paresis of an upper extremity due to 
traumatic stretching of the brachial plexus at birth, with passive greater than active range of 
motion. The incidence varies between countries and is approximately 1.5 cases per 1,000 live 
births
42 , 45
. 
Brachial plexus injury is characteristically related to shoulder dystocia; however, such 
complications can occur following normal spontaneous vaginal delivery and caesarean 
section
46
. Both excessive exogenous traction and strong endogenous pushing forces 
contribute to brachial plexus injury BPI
47
. The second most important risk factor for BPI is 
heavy birth weight
43
, which is associated with a 14-fold increase in risk
45
. In one study, the 
prevalence of BPI progressively increased with infant weight, occurring in only 3% of 
neonates in the 4,500–5,000 g group and 6.7% in the >5,000 g group48.  
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Moreover, the risk is further increased when macrosomia and gestational diabetes coexist, 
with an adjusted OR of 42 (95% CI 4.05–433.64)43.  
It has also been reported that BPI among infants weighing ≥4,000 g is more likely to be 
severe and persistent than in the normosomicgroup
49
. Because the two main risk factors for 
congenital BPI, i.e., shoulder dystocia and macrosomia, are not easily predictable, it is 
difficult to foresee and prevent its occurrence
47
. 
1.3.4 Skeletal injuries 
Skeletal injuries commonly occur in the presence of shoulder dystocia and are associated 
with large infants
24, 50
. Fracture of the clavicle is five times more common in macrosomic 
infants, and occurs more often in vaginal delivery than in caesarean section
40, 51
. Humeral 
fractures are less frequent, but also occur in big babies.  Gregory et al in 1998 analysed 
neonatal complications following shoulder dystocia and reported that, unlike brachial plexus 
injury, the risk of having skeletal injuries in macrosomic infants is not higher than in those 
with normal birth weight
40
. Clavicular fractures are usually managed conservatively and the 
outcome is most often benign, with complete recovery and no associated neurologic 
complications. Humeral fractures are managed mainly by closed reduction followed by 
splinting or traction techniques, and usually do not have long-term sequelae. 
1.3.5 Chorioamnionitis 
Significant maternal and neonatal complications can result from the birth of a macrosomic 
infant, and includes chorioamnionitis. The risk of chorioamnionitis slowly and steadily 
increases as birth weight increases, and the ORs are 1.94, 2.17, and 2.42 for birth weight 
groups of 4,000–4,499 g, 4,500–4,999 g, and ≥5,000 g17, respectively. 
1.3.6 Aspiration of meconium 
Aspiration of meconium is a risk associated with macrosomia
29, 32
. Again, the risk increases 
with rising birth weight. The ORs are 1.28, 1.65, and 2.61 for babies with birth weights of 
4,000–4,499 g, 4,500–4,999 g, and >5,000 g, respectively29. However, other investigators 
reported that the association was not statistically significant
23
. 
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1.3.7 Perinatal asphyxia 
The risk of macrosomic neonates suffering from perinatal asphyxia increases 2–4-fold 
compared with that in normosomic infants
23, 40
. The odds of perinatal asphyxia increase 
considerably with rising birth weight; in one study, the OR was2.3 if birth weight was 4,500–
4,999 g and increased further to 10.5 if birth weight was >5,000 g
25
. 
1.3.8 Poor Apgar scores 
There are reports that Apgar scores are poor in infants with macrosomia. The greater the birth 
weight, the higher the risk of low Apgar scores
25, 29
. Boulet et al in 2003 showed the OR for a 
5-minute Apgar score ≤6 was 1.65 and 3.49 for infants with birth weight 4,500–4,999 g and 
>5,000 g, respectively, whereas that for a 5-minute Apgar score ≤3 was even higher, with 
corresponding ORs of 2.01 and 5.
20,29
. Furthermore, the risk of a low Apgar score is eight 
times higher in macrosomic babies when the delivery is complicated by shoulder dystocia
24
. 
In contrast, Weissmann-Brenner et al in 2012 could not demonstrate any statistically 
significant difference in low Apgar scores between normal and big babies
31
. 
1.3.9 Neonatal hypoglycemia 
The risk of neonatal hypoglycemia is higher in heavy babies
43
, and the risk increases with 
increasing birth weight. Neonates with a birth weight >4,500 g had a seven-fold higher risk of 
having neonatal hypoglycemia, compared with those appropriate for gestation age
31
. This risk 
further increases in the presence of gestational diabetes. Infants with a birth weight ≥4,000 g 
delivered by no diabetic mothers had a 2.4% risk of neonatal hypoglycemia, whereas those 
whose mothers had gestational diabetes had an incidence of 5.3%
43
. 
1.3.9.1 Intrauterine fetal death 
Macrosomia has been consistently shown to be associated with a 2–3-fold increase in 
intrauterine fetal death
52
. 
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Zhang et al in 2008 showed that birth weights of 4,000–4,499 g were not at increased risk of 
mortality compared with those born at 3,500–3,999 g; however, those born at 4,500–4,999 g 
had a significantly increased risk of stillbirth (OR 2.7, 95% CI 2.2–3.4) and the risk rose 
dramatically with a birth weight ≥5,000 g (OR 13.2, 95% CI 9.8–17.7)25. Because maternal 
diabetes is closely related to macrosomia and fetal death, Mondestin et al in 2002 addressed 
this complex interaction and showed that the fetal death rate increased in macrosomic fetuses 
in both diabetic and non-diabetic pregnancies, but the cut off birth weight was different, 
being ≥4,250 g in non-diabetic women and ≥4,000 g in their diabetic counterparts53. 
1.3.9.2 Neonatal and infant mortality 
Numerous epidemiologic studies have shown a distinct relationship between birth weight and 
neonatal and infant mortality, and have consistently demonstrated a reverse J pattern of 
weight-specific mortality in all populations, where the mortality rates increase at the extremes 
of birth weight
54
. Compared with a normosomic group of infants with a birth weight of 
3,000–3,999 g, babies with a birth weight >5,000 g had a 2–3-fold increase in risk of neonatal 
death, and a 1.6–2.0-fold increased risk of post neonatal and infant mortality, respectively. 
Such an association was not identified in babies with a birth weight of 4,000–4,999 g29. 
However, a recent study by Zhang et al in 2008, which included close to 6 million births from 
the USA, showed that neonates with a birth weight >4,500 g also had a higher early neonatal 
death rate (OR 1.8), but there was no increase in late or post neonatal death
25
. Early, late, and 
post neonatal deaths were all significantly increased in those weighing ≥5,000 g, with ORs of 
6.4, 5.2, and 2.3, respectively. The leading cause of early neonatal death in macrosomic 
babies was asphyxia. 
Sudden infant death syndrome is another concern for macrosomic babies, but the current data 
are conflicting. The majority of post neonatal deaths reported by Zhang et al in 2008 were 
due to sudden infant death syndrome. Infants with a birth weight ≥5,000 g have a more than 
2-fold increase in risk
25
. However, such a detrimental effect was not identified in other 
studies, and excessive intrauterine growth (birth weight >90th percentile) has even been 
shown to have a protective role in sudden infant death syndrome
55
. 
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1.4 Long-term complications 
The Barker hypothesis explains the concept of fetal programming in utero, such that events 
during early development have a profound impact on the risk for development of future adult 
disease. Birth weight has been shown to be predictive of a number of adult diseases, such as 
hypertension, obesity, and insulin resistance
56
. Alternative explanations for the association 
between fetal growth and later diseases, mainly genetic factors, have also been proposed. 
Increased birth weight has been shown to have a positive association with overweight, insulin 
resistance, and metabolic syndrome in later life. The risk of developing metabolic syndrome 
in childhood is highest when there is coexistence of macrosomia and maternal gestational 
diabetes, and is comparatively less marked in the group with macrosomia alone
57
. 
Interestingly, breast cancer has been found to be associated with high birth weight in 
numerous studies
58. Those with particularly high birth weight (≥4,500 g) had the most 
pronounced elevation in risk (OR 3.10, 95% CI 1.18–7.97). It is postulated that this 
association is mediated in part by hormonal mechanisms that positively influence fetal 
growth and mammary gland development. 
1.5 Prenatal diagnosis of fetal macrosomia 
Prenatal estimation of fetal weight is notoriously known to be inaccurate, with errors 
exceeding 10% of the actual birth weight
59
. In fact, sonographic estimates of birth weight are 
no better than clinical assessment. The sonographic detection of macrosomic infants >4,000 g 
is even more unreliable, with a low sensitivity, low positive predictive value
60
. Different 
formulae for estimated fetal weight have been evaluated and the prediction of macrosomia is 
poor. The mean detection rates for fetuses with a birth weight of ≥4,000 g, ≥4,300 g, and 
≥4,500 g were 29%, 24%, and 22%, respectively, and false positive rates were 12% (for 
≥4,300 g) and 7% (for ≥4,500 g)61. Moreover, many researchers have developed additional 
assessment methods to improve the detection of macrosomia, including two-dimensional and 
three-dimensional assessment of fetal subcutaneous and soft tissue.  
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However, these methods are more time-consuming and technically demanding. Recently, a 
new formula has been shown to be superior to the traditional formulae for prediction of 
macrosomia, where 78% of estimates fell within ±5% of the actual weight at birth, 97% 
within ±10%, and 100% within ±15% and ±20%
62
. 
1.6 Management of fetal macrosomia 
The management of suspected fetal macrosomia continues to be an obstetric challenge. This 
is due to the inaccuracy of prenatal clinical or sonographic diagnosis as discussed above, and 
also because of the difficulty in prediction of its complications during labour, in particular, 
the risk of shoulder dystocia
42, 63
. 
The most effective way to manage macrosomia is probably by prevention. Two of the most 
important risk factors for macrosomia which can be modifiable are maternal obesity and 
gestational diabetes. The risk of macrosomia increases with the severity of maternal obesity
64
. 
Weight loss and also reduction in body mass index between the first and second pregnancies 
can reduce the risk of large for gestational age births
65
. Achieving optimal glycaemic control 
in diabetic women, especially postprandial glucose control, can also prevent macrosomia and 
reduce the incidence of shoulder dystocia and birth trauma
66
. 
The idea of inducing labour for suspected macrosomia before the baby grows too big, with an 
aim to reduce operative deliveries and birth trauma, has not been supported by clinical 
evidence. Induction of labour for suspected macrosomia in non-diabetic women has not been 
shown to improve either maternal or neonatal outcome
67
. On the other hand, because women 
with diabetes have a higher risk of shoulder dystocia and birth trauma, the National Institute 
for Health and Care Excellence guideline currently suggests that pregnant women with 
diabetes should be offered elective birth by induction of labour after 38 weeks of gestation
68
.  
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Whether elective caesarean section should be performed to prevent BPI is another 
controversial issue. It has been estimated that 443 caesarean sections are required to prevent 
one permanent BPI in diabetic women with an estimated fetal weight >4,500 g, and an 
exceedingly high number (3,695) of caesarean sections are needed to prevent one permanent 
BPI in the non-diabetic population
69
.  
The Royal College of Obstetricians and Gynaecologists and the American College of 
Obstetricians and Gynaecologists recommend elective caesarean delivery in diabetic and non-
diabetic women with estimated fetal weight >4,500 g and >5,000 g, respectively
41, 
70
.However, these guidelines may not be appropriate for the Asian population because the 
birth weight cut-off is too high
42
. 
1.7 Rationale 
Since there has not been any study conducted on macrosomic newborns in Kwa Zulu Natal, 
the present study will help to understand the prevalence, risk factors and maternal, fetal and 
neonatal complications of macrosomic newborns in the region. It will also draw attention of 
policy makers to improve the maternal and child health status in the region along with 
helping the fight for the present obstetrics challenges in Kwa Zulu Natal. It will therefore 
contribute to the academic discourse on reproductive health within the discipline of public 
health and most likely will come up with the ideas for future research on the subject. 
Considering increased risks of complications related to delivery of macrosomic fetuses the 
aim of this research was to determine the incidence, risk factors and perinatal outcome 
associated with giving birth to macrosomic babies weighing four or more kilograms.  
 
1.8 Objectives 
1. The profile of pregnant women with risk factors for fetal macrosomia 
2. The maternal outcome associated with fetal macrosomia 
3. The fetal outcome associated with fetal macrosomia 
 
1.9 Hypothesis  
Fetal macrosomia is associated with an increased risk of maternal and fetal complications 
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Methodology  
2.0 Study Location 
King Edward VIII Hospital, Durban, Kwazulu Natal. 
2.1 Study period 
1
st
July 2012 to 1
st
July 2013. 
2.2 Study Design 
 A retrospective chart audit. All information was obtained from chart reviews. 
2.3 Study Population 
All women who delivered macrosomic infants at King Edward VIII Hospital from 1
st
July 
2012 to 1
st
July 2013 were included. 
2.4 Sample Size 
Using a single proportion formula with degree of confidence of 1.65 and prevalence of 3.4% 
as according to the previous study 
15
, 50 mothers were required as study subjects. However a 
total of 238 mothers were enrolled in this study. 
2.5 Inclusion Criteria  
Singleton pregnancies 
Gestational age of term pregnancies (37 to 42 weeks) 
2.6 Exclusion Criteria  
Multiple pregnancies 
Pregnancies complicated by intrauterine growth restriction 
Patients with incomplete data were excluded                        
2.7 Data collection  
 
Demographic, obstetrical characteristics and maternal, fetal, neonatal, and pregnancy 
outcomes of macrosomic infants were recorded in a structured format 
12 
 The following parameters were recorded in a structured format (Appendix 1). 
 Demographic profiling 
 Co morbidities 
 Socio-economic status 
 Past obstetric history 
 Maternal complications 
 Neonatal complications. 
 Length of mothers stay in hospital 
 
BMI was categorized in the following groups, according to the Guidelines of American 
Clinics for the identification, evaluation and treatment of obesity and overweight in adults: 
normal weight (BMI 18.5–24.9 kg/m2), overweight (BMI 25–29.9 kg/m2) and obese (BMI 
≥30 kg/m2) 71. Age was grouped as follows: < 25 years, 25-35 years and > 35 years. 
 
2.8 Statistical Planning 
Data were captured on a customised MS Excel spread sheet and analysed using SPSS version 
23.  The Pearson’s correlation coefficient was utilised for the correlation between weight of 
the newborn and gestational age at delivery or neonatal complications. A p value <0.05 was 
considered significant. 
 
2.9 Ethical Consideration 
Ethics approval was obtained from the University of KwaZulu Natal Biomedical Research 
Ethics Committee (BE: 055/15) for a retrospective review of data, analysis and publication. 
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Results 
3.0 Demographic data 
There were 6932 deliveries during the one year study period. Of this 238 were macrosomic 
deliveries. The prevalence of macrosomic newborns was 3.4%. The mean age of mothers that 
had macrosomic babies was 26.6 ± 5.8 (range: 14 – 41) years.  Eighty nine (37.4%) mothers 
were aged ≤ 20 years, 122 (51.3%) were aged between 21 – 30 years, 26 (10.9%) were aged 
between 31 – 40 years and one (0.4%) was aged between 41-50 years. The maximum 
frequency of macrosomic births occurred in women in the 21-30 year age group. There was 
no significant difference in the mean birth weight of macrosomic babies with shoulder 
dystocia and those without shoulder dystocia (4180.7 ± 278.7g vs. 4204. 0 ± 188.6g, P = 
0.64).Body mass index was categorized as follows:  Two (0.8%) were of normal BMI, 90 
(36.2%) mothers were overweight and 159 (63%) were obese. 
The mean (SD) parity was 1.3 ± 1.2 (range: 0 – 7). Seventy two (30.3%) of the mothers were 
para 0, 132 (55.5%) were between para 1 and para 2, 30 (12.6%) were between para 3 and 
para 4 and 4 (1.6%) between para 5 and para 7. The mean (SD) gravidity was 2.4 ± 1.3 
(range: 1 – 8). Two hundred and thirty four (98.3%) mothers attended antenatal care with a 
mean number of antenatal visits of 6.6 ± 2.5 (range: 1 – 16). The mean gestational age at 
booking for antenatal care was 21.3 ± 7.4 (range 4 – 40) weeks. The mean (SD) gestational 
age at delivery of 209 (87.8%) mothers was 39.7 ± 1.2 (range: 37 – 42) weeks. In 29 (12.2%) 
mothers gestational age at delivery was 42+ weeks. (Table 1) 
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Table 1: Patient demographic profiles 
Variables  Number  
N=238 
Percentages 
Age (26.6 ± 5.8 (range: 14 – 41) years. 
Age groups  
< 20 
         21-30 
         31 – 40 
         41 - 50       
Body mass index (35.6±6.4) range (24 - 61) 
BMI groups 
      Normal  
      Overweight 
      Obese 
Parity:  1.3 ± 1.2 (range: 0 – 7) 
      0 
      1 – 2 
      3 – 4 
      5 – 7 
Gravid  2.4 ± 1.3 (range: 1 – 8) 
1 - 2 
3 – 4 
5 – 8 
Antenatal visits: 6.6 ± 2.5 (range: 1 – 16) 
1 - 4 
5 - 8 
9 - 16 
Gestational age (weeks) 
     At booking     21.3 ± 7.4 (range 4 - 40) 
     At term(n=209)    39.7 ± 1.2 (37 – 42) 
    At post term  (n=29)      42+ 
 
 
89 
123 
26 
1 
 
 
2 
90 
159 
 
72 
132 
30 
4 
 
197 
23 
18 
 
46 
154 
34 
 
 
 
 
 
 
37.4 
51.3 
10.9 
0.4 
 
 
0.8 
36.2 
63.0 
 
30.3 
55.5 
12.6 
1.6 
 
82.8 
9.7 
7.6 
 
19.3 
64.7 
14.3 
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 3.1 Laboratory variables 
The mean (SD) haemoglobin was 10.9 ±1.2   (range: 7.5- 14.5).  Two hundred and thirty five 
(98.7%) was rhesus positive. The RPR was negative in 98.3% of the patients. One hundred 
and sixty (67.2%) were HIV negative. 
Table2: Laboratory variables  
Variable Number  
n=238 
Percentage 
Haemoglobin: (mean : 10.9 ±1.3)   (range: 7.5- 14.5) 
Rhesus factor 
Positive 
Negative 
RPR 
          Positive  
          Negative 
HIV status 
           Negative 
           Positive  
 
 
235 
3 
 
4 
234 
 
160 
78 
 
 
98.7 
1.3 
 
1.7 
98.3 
 
67.2 
32.8 
 
 
 
3.2 Obstetric condition at presentation 
 
Table 3 lists the 95 (39.9%) mothers who presented with obstetric conditions: 3 (1.3%) 
mothers were diabetic and 2 (0.8%) mothers developed gestational diabetes but of the 
medical conditions in pregnancy,  hypertensive complications were the main problem. 
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Table 3: Obstetric condition at presentation 
 
Obstetric condition at presentation Frequency  
n=95 
% of the total 
macrosomic 
population 
Diabetes 
Gestational diabetes 
Previous CS (x1 and 2 or more) 
Hypertension complications of pregnancy (n=21) 
     Pre-eclampsia 
     Gestational hypertension  
Abruptio placenta 
Multifibroid uterus 
Breech  
High body mass index 
Termination of pregnancy 
Tuberculosis 
Advanced maternal age  
Asthma 
Polyhydramnios 
Teenage pregnancy 
3 
2 
45 
 
12 
9 
1 
1 
1 
3 
1 
1 
4 
1 
5 
6 
1.3 
0.8 
18.9 
 
5.0 
3.8 
0.4 
0.4 
0.4 
1.3 
0.4 
0.4 
1.7 
0.4 
2.1 
2.5 
 
3.3 Socio-economic variables of the mothers 
Majority of the mothers were single (90.3%); 14.3% were employed and 0.8% consumed 
alcohol.  Among mothers, 0.4% had smoking habits. Details of the socio-economic variables 
are shown in Table 4. 
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Table 4: Socio-economic variables of the mothers  
Socioeconomic details Yes   No 
Employment       
Smoking        
Alcohol consumption 
Marital status 
          Single  
          Married 
34 (14.3%)  
1 (0.4%) 
2 (0.8%) 
 
215 (90.3%) 
23 (9.7%) 
204 (85.7%) 
237 (99.6%) 
236 (99.2%) 
 
 
 
 
 
3.4 Previous macrosomic history 
 
Thirty five (14.7%) mothers gave previous history of delivering macrosomic infants. All 
mothers delivered at term. Neonatal outcome showed that 227(95.4%) were live births, 10 
(4.2%) stillbirths and one (0.4%) neonatal death.  
 
3.5 Co-morbidities 
Co-morbidities are listed in Table 5. Four (1.7%) had asthma, twenty one (8.8%) had 
hypertensive complications of pregnancy, two (0.8%) had thyroid disorder, three (1.3%) had 
diabetes and two (0.8%) had tuberculosis successfully treated.  
Table 5: Co-morbidities  
 
Co-morbidities (n=33) Number (n)                          Percentage (%) 
Asthma 
Anaemia 
Peripartum cardiomyopathy 
Hypertensive complications of pregnancy 
Thyroid disorder 
Epilepsy  
Diabetes 
4 
1 
1 
21 
2 
1 
3 
1.7 
0.4 
0.4 
8.8 
0.8 
0.4 
1.3 
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 3.6 Maternal outcomes 
Labour was induced in 13.4% of the mothers. Fourteen(5.9%) mothers experienced 
prolonged second stage of labour and shoulder dystocia occurred in 2.4% of the deliveries. 
 
 
3.6.1 Mode of delivery 
 
One hundred and fifty three (64.3%) delivered by CS, 109 (71.2%) by emergency CS and 44 
(28.8%) by elective CS. Eighty five (35.7%) delivered by normal vaginal delivery. Elective 
episiotomy was done in most cases of vaginal deliveries. The three main indications for CS 
were previous CS (29.4%), fetal distress (27.5%) and cephalo-pelvic disproportion (14.4%). 
Indications for CS are shown in Table 6. 
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Table 6: Indications for CS 
 
Indications for CS (n=153) Number (n)                          Percentage (%) 
Emergency CS (n=109) 
     Fetal distress                                        
     Cephalo pelvic disproportion              
     Poor progress                                      
     Ante partum haemorrhage 
     Previous CS                                        
     MSL 2/3 
     Failed induction                                   
     Failed VBAC                                            
     Breech                                                                                          
     Delayed 2
nd
 stage                                 
     Gestational hypertension                                                           
     Preeclampsia                                                                                
Elective CS (n=44) 
     Previous CS                                                                            
     Failed induction of labour 
     Big baby                                                                                   
 
 
 
42 
 
22 
 
8 
 
4 
 
11 
 
6 
 
3 
 
3 
 
5 
 
3 
 
1 
 
1 
 
 
 
34 
 
4 
 
6 
 
 
27.5 
 
14.4 
 
5.2 
 
2.6 
 
7.2 
 
3.9 
 
1.9 
 
1.9 
 
3.3 
 
1.9 
 
0.7 
 
0.7 
 
 
 
22.2 
 
2.6 
 
3.9 
3.6.2 Maternal complications  
Overall, 58 patients (24.4%) presented with maternal complications. First degree perineal 
tears occurred in 9 (10.6%) women, 2nd degree in 19 (22.4%), cervical lacerations in 1 
(0.4%). Twenty nine (12.2%) experienced postpartum hemorrhage. (Table 7) 
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Table 7.Complications experienced by mothers following delivery of macrosomic 
babies either by normal vaginal delivery and caesarean delivery 
Normal vaginal delivery(n=85)                 Number (n)       Percentage (%) 
       1
st
 degree tear                                             9                   10.6 
        2
nd
 degree tear                                           19                 22.4   
        3
rd
 degree tear                                             0                     0 
        Cervical lacerations                                   1                  1.2 
Post-partum haemorrhage                                   12                14.1 
          (2
nd
degree tear (n=8); cervical laceration (n=2); unknown (n=1) and episiotomy (n=1)) 
Caesarean delivery (n=153) 
Post-partum haemorrhage                                  17                11.1 
           (elective CS (n=2) and emergency CS (n=15) 
 
 
 
3.7 Neonatal outcome 
There were 237 (99.6%) live birth infants and one (0.4%) stillbirth. There was a 
preponderance of male infants with macrosomia with the male to female ratio of 2.0 to 1.One 
hundred and fifty three (64.3%) of the infant were male and 85 (35.7%) were female. 
Birth weight ranged between 4000 and 5500 g. The majority (92%) of newborns had a birth 
weight between 4000 and 4499 g (Table 8), the mean and median birthweight was 4201 ± 
201.8 g and 4160 g respectively.  Subgroup analysis showed that there was no difference in 
the mean birth weight of macrosomic babies delivered by CS compared to macrosomic 
babies delivered vaginally (4210.3  ± 212.5 g vs 4178.5 ± 172.0g; p=0.2).  
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Table 8. Frequency of macrosomia according to birth weight (data presented as 
number (n) and percentage (%), (n = 238). 
Variable Number (n) Percentage (%) 
Birthweight (gm) 
4000 – 4499 
4500 – 4999 
≥ 5000 
Sex of newborn 
     Male 
     Female 
 
219 
17 
2 
 
153 
85 
 
92.0 
7.2 
0.8 
 
64.3 
35.7 
 
The 5 minute Apgar score was greater than 7 in 98.8% of cases. Eighty (33.8%) macrosomic 
infants experienced complications (Table 9). Two hundred and thirty seven (99.6%) 
newborns were admitted to nursery for observations and as a precautionary measure for a 
median duration of 1 day (range 1–11). Twenty (8.4%) infants were resuscitated. Commonly 
observed complications were respiratory distress (3.4%), hypoglycemia (18.6%) and neonatal 
jaundice (5.1%).The stillbirth rate in the macrosomic infants was 0.4%, but no maternal 
deaths occurred. One of the macrosomic infants died at two years. 
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Table 9: Neonatal complications observed in macrosomic infants 
 
Neonatal complications  Number (n)                          Percentage (%) 
Meconium stained liquor  (2/3) 
Erbs palsy  
Birth trauma   
Transient tachypnea of the newborn 
Cardiac abnormality  
Sepsis  
Hypoglycemia 
Respiratory distress syndrome  
Neonatal jaundice    
Rapid plasma reagin exposure  
Neonatal seizures                                                                                                                                                                                 
3 
2 
2 
3 
1 
2 
44 
8 
12 
1 
2 
1.3 
0.8 
0.8 
1.3 
0.4 
0.8 
18.6 
3.4 
5.1 
0.4 
0.8
 
 
No correlation was found between the weight of the newborn and the different parameters. 
However correlation was found between weight of newborn and gestational age at delivery 
(R=0.172; p=0.008). Moreover, macrosomia increased neonate hypoglycemia and CS 
delivery. 
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Chapter 4 
4.0 Discussion 
The main risk factors for macrosomia in our study were delivery of a previous macrosomic 
baby, hypertensive disorders of pregnancy, male sex, BMI > 25 kg/m
2, parity ≥1, diabetes 
and increased gestational age at delivery. This is consistent with risk factors with regards to 
previous delivery of macrosomic babies 
72, 73
, postmaturity
72, 74, 75
, diabetes 
76 – 78
and 
increased BM1 
79, 80
. 
It has been reported that 38 – 40% of macrosomic babies are born to mothers with at least one 
identifiable risk factor 
81
. Strehlow et al (2007) in this study reported that fewer than 40% of 
mothers had at least one risk factor for macrosomia
82
. In addition, in contrast to findings in 
other studies, maternal age and parity 
17, 81, 83
, were not significantly associated with 
macrosomic deliveries in our study. This may be due to the small size of the study population 
or the influence of genetic, racial or ethnic factors 
22
.
 
Diabetes, pre-existing or gestational diabetes has been reported to be between 1-2% in the 
mothers of macrosomic babies 
84
 with incidence increasing to 5–7% with births of 4500 g and 
greater 
81, 85
. Some studies have reported incidence of diabetes as high as 12.7 -19.5 %
1, 86
.In 
our study, 2.1% of our patients who delivered macrosomic babies had pre-existing diabetes 
and gestational diabetes. 
The maternal complications were high in our audit compared to other studies. The overall 
maternal complications in this study was 24.4% (n=58) which is much higher than the 
reported overall rate of 3.1 – 7.3% 87, 88. Main maternal complications in this study were 
postpartum hemorrhage, perineal tears and cervical lacerations in 25.2%, 33% and 1.2% 
respectively versus 1.2%, 1.7% and 0.7% in an alternate study 
88
. However, another study 
reported   postpartum haemorrhage and perineal tears in 17% and 37%  patients respectively 
87
. Perineal tears and postpartum hemorrhage increases 2 and 3-5 fold respectively in 
macrosomic  deliveries 
37, 89
. 
The overall complications in our macrosomic infants was 33.6% (n=80) in this study which is 
in accordance with other studies
90, 91
.Complication rates as low as 5.3- 16% 
1, 43, 92, 93
and high 
as 44.3 – 88% have been reported 10, 75. The frequency of neonatal hypoglycaemia was the 
most common complications reported in majority of the studies. In our study neonatal 
hypoglycemia occurred in 18.6% cases compared to 34% in another study 
94
. 
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Stillbirth rate (0.4%) is much lower than reported in other studies, 6 – 12% 95, 96. The low 
stillbirth rate in this study is similar to rate in a recent study, 1.3% 
86
. The low stillbirth rate 
was probably due to knowledgeable anticipation and astute supervision with timely decision 
on the labour and delivery process and was vital to a desirable outcome.  
 
The incidence of fetal macrosomia in our study was 3.4% which was similar to other studies 
15, 86
, lower than the rates of 5.5- 10% reported elsewhere 
73, 74, 97, 98 
but higher than 1.3 – 2.3 
% 
75, 99
.  These differences in incidence may be due to differences in the definition of fetal 
macrosomia, differences in geographical and socioeconomic factors of the study population. 
 
Shoulder dystocia, one of the main perinatal difficulties with the delivery of macrosomic 
babies, occurs infrequently with an incidence ranging from 0.2–9.5% of all vaginal deliveries 
86, 100
. In an earlier study, El Fekih et al (2011) reported shoulder dystocia occurred in 1·9% 
of all vaginal deliveries
101
. In our study, shoulder dystocia was noted in 2.4% cases.  Labour 
was induced in 13.4%, probably for maternal - fetal reasons such as hypertension, diabetes or 
oligohydramnios. 
 
The birthweights of the new born was between 4000 and 4499 g in 92% of cases; 7.2% 
between 4500-4999g and 0.8% for 5000g and above. Bekdas et al (2013) reported 88% of the 
macrosomic infants had birth weights between 4000-4499g, 11% between 4500-4999g and 
1% 5000g and above
102
. In the study of Demiroren et al (2008), these rates were 68%, 24% 
and 8% respectively
103
, and in the study of Akin et al (2010) these rates were 80%, 17% and 
3% respectively
104
. The same results were reported by most authors 
10, 105
. Fetal sex 
influences macrosomia potential. Male infants weigh more than female infants at any 
gestational age. Recent studies have confirmed this association 
106
. In our study, sex of the 
infant influenced the birth weight, macrosomia was more dominant in male with 64%, and 
this is consistent with other authors 
10, 107
. Previous history of macrosomic baby is the main 
maternal risk factor to macrosomia 
85, 108
. It has 95% positive predictive value for 
macrosomia 
109
.  In our study, 14.16% of women had a past history of macrosomia. Other 
studies have shown rates as high as 25.9% or more 
1, 18, 86, 110, 111.
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Multiparity ≥ 3 has been associated with macrosomia14, 101, 112, 113. This study did not find this 
association, majority of the macrosomic babies were born to para 1 and 2. Body mass index 
more or equal to 25 has been shown by several authors to be a risk factor for macrosomia 
18, 
110, 114 - 117
. Our study corroborate the BMI ≥25 as a risk factor 
 
According to Kraïem et al (2004) CS is justified in all cases of fetal weight estimation greater 
than 4500 g118. Many studies reported a higher rate of vaginal delivery compared to caesarean 
delivery when macrosomia is concerned 
86, 101, 108, 119
. 
 
Caesarean section delivery rate of 64.3% was high in our study compared to other studies 
86, 
101, 108
. In our study, the high CS rate was as a result of an increased number of women with 
previous CS and our study site policy was to deliver mothers with previous CS carrying a 
fetus weighing ≥of 3400 g by CS. 
 
4.1 Limitations 
 
This being a retrospective study, the following were observed: The history of previous fetal 
macrosomia in the patients or their relations was not documented in most of the files of the 
patients.  
 
4.2 Conclusion 
 
The prevalence of macrosomia was 3.4%.Main risk factors for macrosomia were previous 
history of macrosomia, male sex, hypertensive disorders of pregnancy, body mass index ≥25, 
para 1 and 2, diabetes and higher gestational age at delivery. Mother and neonate are at 
increased risk of complications. 
 
4.3 Recommendations 
 
1. Long term follow up of macrosomic infants are recommended  
2. Management of suspected macrosomia should be individualized with the aim to minimize 
maternal and fetal complications 
3. Regular obstetric drills should be conducted  
4. A study comparing the incidence of macrosomia of our diverse population in our setting is 
needed 
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 Chapter 6: Appendices 
Appendix 1: Data Sheet 
1. Study No:         
2. Date Of Delivery:  
3. Maternal BMI: 
4. Age: 
5. Parity: 
6. Gravidity: 
7. Booked :( Y=1,N=2) 
8. Booking  Gestational  Age: 
9.  Gestational Age at delivery: 
10. Number of Antenatal visits:   
11. Ethnic Group: ( African=1, Indian=2, Coloured=3,white=4) 
12. RH: 
13. RPR: (+ve=1, -ve=2) 
14. HB: 
15. HIV Status(neg=1, pos=2) 
16. Maternal obstetric condition: ( Overt diabetic=1, gestational diabetic=2,  
Other=3) 
 
     17.Socioeconomic 
17.1 Employed:   (Y=1, N=2) 
17.2 Cigarette smoke: (Y=1, N=2)   
17.3 Alcohol use:(Y=1,N=2) 
17.4 Marital  Status: ( single=1, married=2, divorced=3, engaged=4) 
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18.Past Obstetric History 
     18.1 Previous big baby:(Y=1,N=2) 
     18.2 Gest Age at delivery: 
     18.3 Outcome:( 1=alive, 2=SB, 3=ENND, 4=LNND) 
 
19. Past medical history 
( Diabetes mellitus=1, Thyroid disorder Anaemia=3, Hypertension=4, 
       Cardiac disease=5, Epilepsy=6) 
 
20. Maternal Outcomes 
      20.1 Induction of  labour:(Y=1, N=2) 
      20.2 Prolonged second stage:( Y=1,N=2) 
      20.3 Elective caesarean delivery 
      20.4 Emergency caesarean delivery 
      20.5 Instrumental vaginal delivery 
      20.6 Shoulder dystocia 
      20.7 Second and third degree perineal tear 
      20.8 Fourth degree perineal tear 
      20.9 Post-partum haemorrhage 
      20.10 Length of stay>3 days 
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21. Foetal outcome 
      21.1 Male gender 
      21.2 Birth weight 
      21.3 Apgar’s: 
      21.3.1   1
st
  min 
      21.3.2   5
th
  min 
 
 
 21.4 Outcome:( 1=alive, 2=SB, 3= ENND, 4=LNND) 
      21.5 Congenital abnormality:( Y=1, N=2) 
       21.6 Resuscitation 
       21.7 Intensive care unit/nursery 
       21.8 Neonatal complications:( neonatal seizures=1, Erb’s palsy=2 
( birth trauma=3, other=4) 
       21.9 Number of days in nursery: 
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